Tesla’s Bold Gamble – Robotaxis, Rising Sales, and the High-Stakes Road to AutonomySeptember 24, 2024
Tesla’s Bold Gamble – Robotaxis, Rising Sales, and the High-Stakes Road to AutonomySeptember 24, 2024
2024 Heisman Update: Cam Ward REMAINS favorite, Travis Hunter & Jalen Milroe a moment awaySeptember 24, 2024
Ryan Wilson’s EARLY 2025 NFL Mock Draft Picks: Shedeur Sanders and Travis Hunter in top 3, & MORESeptember 24, 2024
Share Facebook Twitter LinkedIn Pinterest Email Michelle Ross, StemPoint Capital CIO and Novo Nordisk shareholder, joins CNBC’s ‘Closing Bell’ to discuss the criticism Novo has faced around high drug prices, the potential earnings impact if prices come down, and more.